Activation of Sigma 1 Receptor Preserves Visual Function After Optic Nerve Injury.
Wang Jing, Xu Zhimin, Caldwell Ruth
AI Summary
Post-injury Sig1R activation preserved visual function, retinal structure, and reduced neurodegeneration after optic nerve injury. This suggests a promising therapeutic strategy for optic nerve damage.
Abstract
Purpose
Previous research has indicated that sigma 1 receptor (Sig1R) activation can help retinal ganglion cells (RGCs) survive optic nerve injury. However, in these studies, the treatments were given before the injury. We explored whether activating Sig1R as a post-injury treatment can still preserve visual function.
Methods
Wild-type or Sig1R knockout mice were subjected to optic nerve crush (ONC) injury. The contralateral eye served as sham control. Starting 6 hours after ONC, (+)-pentazocine, or (+)-PTZ, was administered daily. Visual acuity, contrast sensitivity, pattern electroretinography (PERG), visual evoked potential (VEP), and imaging of retinal structure and vasculature were evaluated using OptoMotry, ERG, spectral-domain optical coherence tomography, and fluorescein angiography, respectively. Retinal neurons and RGC survival were assessed in retinal whole mounts, and retinal glial activation was detected through glial fibrillary acid protein (GFAP) immunolabeling on retinal cryosections. Oxidative stress levels were measured with dihydroethidium (DHE) staining. Additionally, quantitative reverse transcription PCR was conducted to analyze changes in mRNA expression related to antioxidant (Nrf2, HO-1, NQO1) and inflammatory (IL1β, TNFα, iNOS) pathways.
Results
Our results indicate that activating Sig1R with (+)-PTZ after ONC injury effectively preserves visual function. This was demonstrated by enhanced visual acuity, contrast sensitivity, PERG, and VEP responses, as well as improved retinal thickness and vasculature in ONC+PTZ mice. Additionally, activation of Sig1R limits ONC-induced neurodegeneration and glial activation caused by ONC by a mechanism involving increasing antioxidant genes expression (Nrf2, HO-1, NQO1) and decreasing retinal inflammation (IL1β, TNFα, iNOS).
Conclusions
These findings suggest that activating Sig1R could be a promising therapeutic approach for preserving visual function even after optic nerve damage.
MeSH Terms
Shields Classification
Key Concepts4
Activating sigma 1 receptor (Sig1R) with (+)-pentazocine ((+)-PTZ) after optic nerve crush (ONC) injury effectively preserves visual function in wild-type mice, as demonstrated by enhanced visual acuity, contrast sensitivity, pattern electroretinography (PERG), and visual evoked potential (VEP) responses, as well as improved retinal thickness and vasculature.
Activation of sigma 1 receptor (Sig1R) with (+)-pentazocine ((+)-PTZ) limits optic nerve crush (ONC)-induced neurodegeneration and glial activation in wild-type mice.
The mechanism by which activation of sigma 1 receptor (Sig1R) with (+)-pentazocine ((+)-PTZ) limits optic nerve crush (ONC)-induced neurodegeneration and glial activation involves increasing antioxidant gene expression (Nrf2, HO-1, NQO1) and decreasing retinal inflammation (IL1β, TNFα, iNOS) in wild-type mice.
Wild-type or Sig1R knockout mice were subjected to optic nerve crush (ONC) injury, with the contralateral eye serving as sham control, and daily administration of (+)-pentazocine ((+)-PTZ) starting 6 hours after ONC, to evaluate the effect of Sig1R activation on visual function.
Related Articles5
A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.
Randomized Controlled TrialEndoplasmic Reticulum Stress Drives Neuroinflammation Through Lipocalin 2 Upregulation in Retinal Microglia After Optic Nerve Injury.
Basic ScienceAddressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments.
ReviewMaraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis.
Basic ScienceThe Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy.
Basic ScienceIs this article assigned to the wrong chapter(s)? Let us know.